InvestSMART

BLS Pharmaceuticals Limited (ASX: BLS) - Announcements

- Current share price for BLS : $0.895

ASX company news and announcements for BLS Pharmaceuticals Limited (BLS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BLS Pharmaceuticals Limited (BLS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BLS Pharmaceuticals Limited (BLS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BLS Pharmaceuticals Limited (BLS)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$211 Application for quotation of securities - BLS 16 Nov 2026 6:49PM $0.895 $0.895 fallen by 0%
$211 To Present at Bell Potter Health Care Conference 19.11.2026 16 Nov 2026 8:42AM $0.855 $0.895 risen by 4.68%
$211 Directors Change of Interest Notice X 2 27 Oct 2026 6:00PM $1.000 $0.895 fallen by 10.50%
$211 Application for quotation of securities - BLS 26 Oct 2026 6:13PM $0.950 $0.895 fallen by 5.79%
$211 Letter to Shareholders re Annual General Meeting 23 Oct 2026 5:01PM $0.935 $0.895 fallen by 4.28%
$211 Notice of Annual General Meeting/Proxy Form 23 Oct 2026 4:48PM $0.935 $0.895 fallen by 4.28%
$211 Q1 FY2027 Quarterly Activities Update 21 Oct 2026 8:56AM $1.000 $0.895 fallen by 10.50%
$211 BLS Quarterly Activities Report September 2026 Revised 15 Oct 2026 9:19AM $1.085 $0.895 fallen by 17.51%
$211 Quarterly Activities/Appendix 4C Cash Flow Report 15 Oct 2026 8:28AM $1.085 $0.895 fallen by 17.51%
$211 Ceasing to be a substantial holder 13 Oct 2026 8:59AM $1.015 $0.895 fallen by 11.82%
$211 Becoming a substantial holder 9 Oct 2026 2:39PM $0.995 $0.895 fallen by 10.05%
$211 AGM Date and Director Nominations 7 Oct 2026 9:54AM $0.975 $0.895 fallen by 8.21%
$211 Application for quotation of securities - BLS 5 Oct 2026 11:46AM $1.000 $0.895 fallen by 10.50%
$211 Application for quotation of securities - BLS 28 Sep 2026 2:49PM $0.985 $0.895 fallen by 9.14%
$211 Initial Director's Interest Notice 15 Sep 2026 8:20AM $1.165 $0.895 fallen by 23.18%
$211 Angus Walker Appointed Alternate Director to Edward Myer 14 Sep 2026 8:25AM $1.180 $0.895 fallen by 24.15%
$211 Application for quotation of securities - BLS 10 Sep 2026 4:36PM $1.180 $0.895 fallen by 24.15%
$211 S&P DJI Announces September 2026 Quarterly Rebalance 4 Sep 2026 5:10PM $1.140 $0.895 fallen by 21.49%
$211 Application for quotation of securities - BLS 4 Sep 2026 5:07PM $1.140 $0.895 fallen by 21.49%
$211 Appendix 4G Corporate Governance Statement 31 Aug 2026 3:03PM $1.045 $0.895 fallen by 14.35%
$211 BLS FY2027 Guidance 31 Aug 2026 12:51PM $0.935 $0.895 fallen by 4.28%
$211 BLS Investor Presentation 31 Aug 2026 12:44PM $0.935 $0.895 fallen by 4.28%
$211 BLS FY2026 Results Announcement 31 Aug 2026 12:37PM $0.935 $0.895 fallen by 4.28%
$211 Annual Report to shareholders 31 Aug 2026 12:36PM $0.935 $0.895 fallen by 4.28%
$211 BLS FY2026 Results Webinar 2 September 2026 8am AEST 27 Aug 2026 11:51AM $0.930 $0.895 fallen by 3.76%

1 - 25 of 74 results

Page 1 of 3

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.